Delivering Two Tumour Antigens Survivin and Mucin-1 on Virus-Like Particles Enhances Anti-Tumour Immune Responses

Delivering Two Tumour Antigens Survivin and Mucin-1 on Virus-Like Particles Enhances Anti-Tumour Immune Responses

Breast cancer (BC) is the most frequently diagnosed cancer in women, with many patients experiencing recurrence following treatment. Antigens delivered on virus-like particles (VLPs) induce a targeted immune response and here we investigated whether the co-delivery of multiple antigens could induce...

Full description

Bibliographic Details
Main Authors: Katrin Campbell, Vivienne L. Young, Braeden C. Donaldson, Matthew J. Woodall, Nicholas J. Shields, Greg F. Walker, Vernon K. Ward, Sarah L. Young
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Vaccines
Subjects:
breast cancer
nanoparticles
virus-like particles (VLPs)
conjugated VLPs
multimeric presentation
therapeutic vaccines
Online Access:https://www.mdpi.com/2076-393X/9/5/463

Internet

https://www.mdpi.com/2076-393X/9/5/463

Similar Items